Skip to main content
Top
Published in: Surgical Endoscopy 11/2019

Open Access 01-11-2019 | Barrett Esophagus

Comparison of two multiband mucosectomy devices for endoscopic resection of Barrett’s esophagus-related neoplasia

Authors: Durayd Alzoubaidi, David Graham, Paul Bassett, Cormac Magee, Martin Everson, Matthew Banks, Marco Novelli, Marnix Jansen, Laurence B. Lovat, Rehan Haidry

Published in: Surgical Endoscopy | Issue 11/2019

Login to get access

Abstract

Background

Esophageal adenocarcinoma carries a poor prognosis and therefore treatment of early neoplasia arising in the precursor condition Barrett’s esophagus (BE) is desirable. Visible lesions arising in BE need endoscopic mucosal resection for accurate staging and removal. Resection modalities include a cap-based system with snare and custom-made multiband mucosectomy (MBM) devices (Duette, Cook Medical Ltd). A new MBM device has recently become available (Captivator, Boston Scientific Ltd).

Objectives

A retrospective pilot study to compare the efficacy, safety, specimen size and histology of endoscopic mucosal resection (EMR) specimens resected with two MBM devices (Cook Duette and Boston Captivator) in treatment naive patients undergoing endoscopic therapy for BE neoplasia.

Methods

Consecutive EMR procedures carried out by a single experienced endoscopist were analysed. All visible lesions were marked and resected using one of the two MBM devices. All resected specimens were analysed by the same two experienced pathologists. The resected specimens in both groups were analysed for maximum diameter, minimum diameter, surface area and depth.

Results

Twenty consecutive patients were analysed (18M + 2F; mean age 74) in the Duette group and 20 (17M + 3F; mean age 72) in the Captivator group. A total of 58 specimens were resected in the Duette and 63 in the Captivator group. Min diameter, max diameter, surface area and depth of the ER specimens resected by the Captivator device were significantly larger than that by the Duette device [min diameter 9.89 mm vs 9.07 mm (p = 0.019); max diameter: 13.54 mm vs 12.38 mm (p = 0.024); surface area: 135.40 mm2 vs 113.89 mm2 (p = 0.005); depth 3.71 mm vs 2.89 (p = 0.001)].

Conclusions

These two MBM devices showed equivalent efficacy and safety outcomes, but the EMR Captivator device resected specimens with a larger area in the esophagus when compared with the Duette device. A possible advantage of this is in situations where en bloc resections with fewer EMRs are desirable for larger lesions.
Literature
1.
go back to reference Spechler SJ (2002) Barrett’s esophagus and esophageal adenocarcinoma: pathogenesis, diagnosis, and therapy. Med Clin N Am 86:1423–1445CrossRef Spechler SJ (2002) Barrett’s esophagus and esophageal adenocarcinoma: pathogenesis, diagnosis, and therapy. Med Clin N Am 86:1423–1445CrossRef
2.
go back to reference Fernando HC, Murthy SC, Hofstetter W, Shrager JB, Bridges C, Mitchell JD et al (2009) The Society of Thoracic Surgeons Practice guideline series: guidelines for the management of Barrett’s esophagus with high-grade dysplasia. Ann Thorac Surg 87:1993–2002CrossRef Fernando HC, Murthy SC, Hofstetter W, Shrager JB, Bridges C, Mitchell JD et al (2009) The Society of Thoracic Surgeons Practice guideline series: guidelines for the management of Barrett’s esophagus with high-grade dysplasia. Ann Thorac Surg 87:1993–2002CrossRef
3.
go back to reference Prasad G, Wang K, Buttar N, Wongkeesong L, Krishnadath K, Nichols F, Lutzke L, Borkenhagen LS (2007) Long-term survival following endoscopic and surgical treatment of high-grade dysplasia in Barrett’s esophagus. Gastroenterology 132:1226–1233CrossRef Prasad G, Wang K, Buttar N, Wongkeesong L, Krishnadath K, Nichols F, Lutzke L, Borkenhagen LS (2007) Long-term survival following endoscopic and surgical treatment of high-grade dysplasia in Barrett’s esophagus. Gastroenterology 132:1226–1233CrossRef
4.
go back to reference Stein HJ, Hutter J, Feith M, von Rahden BHA (2007) Limited surgical resection and jejunal interposition for early adenocarcinoma of the distal esophagus. Semin Thorac Cardiovasc Surg 19:72–78CrossRef Stein HJ, Hutter J, Feith M, von Rahden BHA (2007) Limited surgical resection and jejunal interposition for early adenocarcinoma of the distal esophagus. Semin Thorac Cardiovasc Surg 19:72–78CrossRef
5.
go back to reference Fitzgerald RC, di Pietro M, Ragunath K, Ang Y, Kang JY, Watson P et al (2014) British Society of Gastroenterology guidelines on the diagnosis and management of Barrett’s oesophagus. Gut 63:7–42CrossRef Fitzgerald RC, di Pietro M, Ragunath K, Ang Y, Kang JY, Watson P et al (2014) British Society of Gastroenterology guidelines on the diagnosis and management of Barrett’s oesophagus. Gut 63:7–42CrossRef
6.
go back to reference Weusten B, Bisschops R, Coron E, Dinis-Ribeiro M, Dumonceau J-M, Esteban J-M et al (2017) Endoscopic management of Barrett’s esophagus: European Society of Gastrointestinal Endoscopy (ESGE) position statement. Endoscopy 49:1–8CrossRef Weusten B, Bisschops R, Coron E, Dinis-Ribeiro M, Dumonceau J-M, Esteban J-M et al (2017) Endoscopic management of Barrett’s esophagus: European Society of Gastrointestinal Endoscopy (ESGE) position statement. Endoscopy 49:1–8CrossRef
7.
go back to reference Shimada H, Nabeya Y, Matsubara H, Okazumi SI, Shiratori T, Shimizu T et al (2006) Prediction of lymph node status in patients with superficial esophageal carcinoma: analysis of 160 surgically resected cancers. Am J Surg 191:250–254CrossRef Shimada H, Nabeya Y, Matsubara H, Okazumi SI, Shiratori T, Shimizu T et al (2006) Prediction of lymph node status in patients with superficial esophageal carcinoma: analysis of 160 surgically resected cancers. Am J Surg 191:250–254CrossRef
8.
go back to reference Peters FP, Kara MA, Rosmolen WD, Aalders MCG, Ten Kate FJW, Bultje BC et al (2005) Endoscopic treatment of high-grade dysplasia and early stage cancer in Barrett’s esophagus. Gastrointest Endosc 61:506–514CrossRef Peters FP, Kara MA, Rosmolen WD, Aalders MCG, Ten Kate FJW, Bultje BC et al (2005) Endoscopic treatment of high-grade dysplasia and early stage cancer in Barrett’s esophagus. Gastrointest Endosc 61:506–514CrossRef
9.
go back to reference Pech O, May A, Manner H, Behrens A, Pohl J, Weferling M et al (2014) Long-term efficacy and safety of endoscopic resection for patients with mucosal adenocarcinoma of the esophagus. Gastroenterology 146:652–660.e1CrossRef Pech O, May A, Manner H, Behrens A, Pohl J, Weferling M et al (2014) Long-term efficacy and safety of endoscopic resection for patients with mucosal adenocarcinoma of the esophagus. Gastroenterology 146:652–660.e1CrossRef
10.
go back to reference Rice T, Falk G, Achkar EPR (1993) Surgical management of high-grade dysplasia in Barrett’s esophagus. Am J Gastroenterol 88:1832–1836PubMed Rice T, Falk G, Achkar EPR (1993) Surgical management of high-grade dysplasia in Barrett’s esophagus. Am J Gastroenterol 88:1832–1836PubMed
11.
go back to reference Inoue H, Takeshita K, Hori H, Muraoka Y, Yoneshima H, Endo M (1993) Endoscopic mucosal resection with a cap-fitted panendoscope for esophagus, stomach, and colon mucosal lesions. Gastrointest Endosc 39:58–62CrossRef Inoue H, Takeshita K, Hori H, Muraoka Y, Yoneshima H, Endo M (1993) Endoscopic mucosal resection with a cap-fitted panendoscope for esophagus, stomach, and colon mucosal lesions. Gastrointest Endosc 39:58–62CrossRef
12.
go back to reference Pouw RE, Van Vilsteren FGI, Peters FP, Herrero LA, Ten Kate FJW, Visser M et al (2011) Randomized trial on endoscopic resection-cap versus multiband mucosectomy for piecemeal endoscopic resection of early Barrett’s neoplasia. Gastrointest Endosc 74:35–43CrossRef Pouw RE, Van Vilsteren FGI, Peters FP, Herrero LA, Ten Kate FJW, Visser M et al (2011) Randomized trial on endoscopic resection-cap versus multiband mucosectomy for piecemeal endoscopic resection of early Barrett’s neoplasia. Gastrointest Endosc 74:35–43CrossRef
13.
go back to reference Eluri S, Shaheen NJ (2017) Barrett’s esophagus: diagnosis and management. Gastrointest Endosc 85:889–903CrossRef Eluri S, Shaheen NJ (2017) Barrett’s esophagus: diagnosis and management. Gastrointest Endosc 85:889–903CrossRef
15.
go back to reference Alvarez Herrero L, Pouw RE, Van Vilsteren FGI, Ten Kate FJW, Visser M, Seldenrijk CA et al (2011) Safety and efficacy of multiband mucosectomy in 1060 resections in Barrett’s esophagus. Endoscopy 43:177–183CrossRef Alvarez Herrero L, Pouw RE, Van Vilsteren FGI, Ten Kate FJW, Visser M, Seldenrijk CA et al (2011) Safety and efficacy of multiband mucosectomy in 1060 resections in Barrett’s esophagus. Endoscopy 43:177–183CrossRef
16.
go back to reference Schölvinck DW, Belghazi K, Pouw RE, Curvers WL, Weusten BLaM, Bergman JJGHM (2015) In vitro assessment of the performance of a new multiband mucosectomy device for endoscopic resection of early upper gastrointestinal neoplasia. Surg Endosc 30:471–479CrossRef Schölvinck DW, Belghazi K, Pouw RE, Curvers WL, Weusten BLaM, Bergman JJGHM (2015) In vitro assessment of the performance of a new multiband mucosectomy device for endoscopic resection of early upper gastrointestinal neoplasia. Surg Endosc 30:471–479CrossRef
18.
go back to reference Participants in the paris work shop (2003) The Paris endoscopic classification of superficial neoplastic lesions: esophagus, stomach, and colon. Gastrointest Endosc 58:3–43 Participants in the paris work shop (2003) The Paris endoscopic classification of superficial neoplastic lesions: esophagus, stomach, and colon. Gastrointest Endosc 58:3–43
19.
go back to reference Vahabzadeh B, Seetharam AB, Cook MB, Wani S, Rastogi A, Bansal A et al (2015) Validation of the Prague C&M criteria for the endoscopic grading of Barrett’s esophagus among gastroenterology trainees: a multicenter study. Gastrointest Endosc 75(2):236–241CrossRef Vahabzadeh B, Seetharam AB, Cook MB, Wani S, Rastogi A, Bansal A et al (2015) Validation of the Prague C&M criteria for the endoscopic grading of Barrett’s esophagus among gastroenterology trainees: a multicenter study. Gastrointest Endosc 75(2):236–241CrossRef
20.
go back to reference Hamilton RH, Aaltonen LA (2000) WHO classification of tumours, pathology and genetics of tumours of the digestive system. IARC Press, Lyon Hamilton RH, Aaltonen LA (2000) WHO classification of tumours, pathology and genetics of tumours of the digestive system. IARC Press, Lyon
21.
go back to reference Bhat S, Coleman HG, Yousef F, Johnston BT, McManus DT, Gavin AT et al (2011) Risk of malignant progression in Barrett’s esophagus patients: results from a large population-based study. J Natl Cancer Inst 103:1049–1057CrossRef Bhat S, Coleman HG, Yousef F, Johnston BT, McManus DT, Gavin AT et al (2011) Risk of malignant progression in Barrett’s esophagus patients: results from a large population-based study. J Natl Cancer Inst 103:1049–1057CrossRef
22.
go back to reference Desai M, Saligram S, Gupta N, Vennalaganti P, Bansal A, Choudhary A et al (2017) Efficacy and safety outcomes of multimodal endoscopic eradication therapy in Barrett’s esophagus-related neoplasia: a systematic review and pooled analysis. Gastrointest Endosc 85:482–495CrossRef Desai M, Saligram S, Gupta N, Vennalaganti P, Bansal A, Choudhary A et al (2017) Efficacy and safety outcomes of multimodal endoscopic eradication therapy in Barrett’s esophagus-related neoplasia: a systematic review and pooled analysis. Gastrointest Endosc 85:482–495CrossRef
23.
go back to reference Tomizawa Y, Konda VJA, Coronel E, Chapman CG, Siddiqui UD (2017) Efficacy, durability, and safety of complete endoscopic mucosal resection of Barrett esophagus: a systematic review and meta-analysis. J Clin Gastroenterol 52(3):210–216 Tomizawa Y, Konda VJA, Coronel E, Chapman CG, Siddiqui UD (2017) Efficacy, durability, and safety of complete endoscopic mucosal resection of Barrett esophagus: a systematic review and meta-analysis. J Clin Gastroenterol 52(3):210–216
24.
go back to reference Peters FP, Kara MA, Curvers WL, Rosmolen WD, Fockens P, Krishnadath KK, Ten Kate FJ, Bergman JJ (2007) Multiband mucosectomy for endoscopic resection of Barrett’s esophagus: feasibility study with matched historical controls. Eur J Gastroenterol Hepatol 19:311–315CrossRef Peters FP, Kara MA, Curvers WL, Rosmolen WD, Fockens P, Krishnadath KK, Ten Kate FJ, Bergman JJ (2007) Multiband mucosectomy for endoscopic resection of Barrett’s esophagus: feasibility study with matched historical controls. Eur J Gastroenterol Hepatol 19:311–315CrossRef
25.
go back to reference Haidry RJ, Butt MA, Dunn JM, Gupta A, Lipman G, Smart HL et al (2015) Improvement over time in outcomes for patients undergoing endoscopic therapy for Barrett’s oesophagus-related neoplasia: 6-year experience from the first 500 patients treated in the UK patient registry. Gut 64:1192–1199CrossRef Haidry RJ, Butt MA, Dunn JM, Gupta A, Lipman G, Smart HL et al (2015) Improvement over time in outcomes for patients undergoing endoscopic therapy for Barrett’s oesophagus-related neoplasia: 6-year experience from the first 500 patients treated in the UK patient registry. Gut 64:1192–1199CrossRef
26.
go back to reference Matsuzaki K, Nagao S, Kawaguchi A, Miyazaki J, Yoshida Y, Kitagawa Y et al (2003) Newly designed soft prelooped cap for endoscopic mucosal resection of gastric lesions. Gastrointest Endosc 57:242–246CrossRef Matsuzaki K, Nagao S, Kawaguchi A, Miyazaki J, Yoshida Y, Kitagawa Y et al (2003) Newly designed soft prelooped cap for endoscopic mucosal resection of gastric lesions. Gastrointest Endosc 57:242–246CrossRef
27.
go back to reference Manner H, Pech O, Heldmann Y, May A, Pohl J, Behrens A et al (2013) Efficacy, safety, and long-term results of endoscopic treatment for early stage adenocarcinoma of the esophagus with low-risk sm1 invasion. Clin Gastroenterol Hepatol 11:630–635CrossRef Manner H, Pech O, Heldmann Y, May A, Pohl J, Behrens A et al (2013) Efficacy, safety, and long-term results of endoscopic treatment for early stage adenocarcinoma of the esophagus with low-risk sm1 invasion. Clin Gastroenterol Hepatol 11:630–635CrossRef
28.
go back to reference Crane SJ, Locke GR, Harmsen WS, Zinsmeister AR, Romero Y, Talley NJ (2008) Survival trends in patients with gastric and esophageal adenocarcinomas: a population-based study. Mayo Clin Proc 83:1087–1094CrossRef Crane SJ, Locke GR, Harmsen WS, Zinsmeister AR, Romero Y, Talley NJ (2008) Survival trends in patients with gastric and esophageal adenocarcinomas: a population-based study. Mayo Clin Proc 83:1087–1094CrossRef
29.
go back to reference Pouw RE, Wirths K, Eisendrath P, Sondermeijer CM, Ten Kate FJ, Fockens P et al (2010) Efficacy of radiofrequency ablation combined with endoscopic resection for Barrett’s esophagus with early neoplasia. Clin Gastroenterol Hepatol 8:23–29CrossRef Pouw RE, Wirths K, Eisendrath P, Sondermeijer CM, Ten Kate FJ, Fockens P et al (2010) Efficacy of radiofrequency ablation combined with endoscopic resection for Barrett’s esophagus with early neoplasia. Clin Gastroenterol Hepatol 8:23–29CrossRef
Metadata
Title
Comparison of two multiband mucosectomy devices for endoscopic resection of Barrett’s esophagus-related neoplasia
Authors
Durayd Alzoubaidi
David Graham
Paul Bassett
Cormac Magee
Martin Everson
Matthew Banks
Marco Novelli
Marnix Jansen
Laurence B. Lovat
Rehan Haidry
Publication date
01-11-2019
Publisher
Springer US
Published in
Surgical Endoscopy / Issue 11/2019
Print ISSN: 0930-2794
Electronic ISSN: 1432-2218
DOI
https://doi.org/10.1007/s00464-018-06655-0

Other articles of this Issue 11/2019

Surgical Endoscopy 11/2019 Go to the issue